Parallax Volatility Advisers’s Array Biopharma Inc ARRY Stock Holding History

Parallax Volatility Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,000	Closed	-$695K	–	3920
2019 Q2	$695K	Sell	15,000 -131,000	-90%	-$3.68M	﹤0.01%	1406
2019 Q1	$3.56M	Buy	146,000 +40,000	+38%	+$833K	﹤0.01%	787
2018 Q4	$1.51M	Hold	106,000	–	–	﹤0.01%	1165
2018 Q3	$1.61M	Buy	+106,000	New	+$1.62M	﹤0.01%	1100
2017 Q4	–	Sell	-65,000	Closed	-$800K	–	5289
2017 Q3	$800K	Sell	65,000 -17,500	-21%	-$163K	﹤0.01%	1136
2017 Q2	$691K	Buy	+82,500	New	+$675K	﹤0.01%	1145
2015 Q4	–	Sell	-160,000	Closed	-$730K	–	4295
2015 Q3	$730K	Buy	+160,000	New	+$949K	﹤0.01%	1406

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Parallax Volatility Advisers's ARRY Position: Q3 2019 in Review

Parallax Volatility Advisers sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 42 shares — an estimated $2K sold.

Parallax Volatility Advisers first reported a position in ARRY in Q2 2015 and held it in 10 quarters. The position peaked at $2.49M in Q4 2015. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Parallax Volatility Advisers reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 42 Array Biopharma Inc shares in Q3 2019, an estimated $2K.
Parallax Volatility Advisers first reported a position in Array Biopharma Inc in Q2 2015 and held it in 10 quarters.
Parallax Volatility Advisers's Array Biopharma Inc position peaked at $2.49M in Q4 2015.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Parallax Volatility Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.